Paychex Inc: Form 10-Q for the period ended Feb 29, 2024
Filed with the SEC on Apr 2, 2024 and accepted by EDGAR at Apr 2, 2024, 16:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-02-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-01 to 2024-02-29 | $1.40bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-06-01 to 2024-02-29 | $3.88bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-12-01 to 2024-02-29 | $379.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-06-01 to 2024-02-29 | $1.10bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2023-12-01 to 2024-02-29 | $409.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-06-01 to 2024-02-29 | $1.19bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-12-01 to 2024-02-29 | $649.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-06-01 to 2024-02-29 | $1.69bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-12-01 to 2024-02-29 | $9.9m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-06-01 to 2024-02-29 | $27.8m | us-gaap:InterestExpense |
| Income tax | 3 months2023-12-01 to 2024-02-29 | $160.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-06-01 to 2024-02-29 | $415.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-01 to 2024-02-29 | $498.6m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2023-12-01 to 2024-02-29 | $1.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-06-01 to 2024-02-29 | $3.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-01 to 2024-02-29 | $1.39 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-06-01 to 2024-02-29 | $3.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-01 to 2024-02-29 | 361,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-06-01 to 2024-02-29 | 362,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-06-01 to 2024-02-29 | $1.68bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-06-01 to 2024-02-29 | $120.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-06-01 to 2024-02-29 | $962.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2023-06-01 to 2024-02-29 | $169.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-02-29 | $1.69bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-02-29 | $9.89bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-02-29 | $13.02bn | us-gaap:Assets |
| Current liabilities | At period end2024-02-29 | $8.00bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-02-29 | $9.28bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-02-29 | $798.5m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2024-02-29 | $18.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-02-29 | $3.75bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-02-29 | 359,963,341 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-24-040129. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.